eTheRNA (private company)

See something wrong or missing? Let us know
Offices:Antwerp
Business model:B2B

eTheRNA is a Belgian developer of mRNA therapeutics that target the fundamental role of dendritic cells in the human immune system.

Investors: we tracked 10 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 77.84M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Top